Scholarlink

Aripiprazole is an atypical antipsychotic with a proposed mechanism of action via dopamine D2 receptor partial agonism. Abilify Maintena® is the first long-acting antipsychotic (LAI) injection via this novel mechanism. This chapter provides clinical pearls on how to appropriately prescribe and administer Abilify Maintena®.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Aripiprazole Monohydrate (Abilify Maintena®): Second-Generation Antipsychotic Long-Acting Injectable

  • 章节

  • 发表日期：

    2025年

查看全文
  • Megan J. Ehret

摘要

Aripiprazole is an atypical antipsychotic with a proposed mechanism of action via dopamine D2 receptor partial agonism. Abilify Maintena® is the first long-acting antipsychotic (LAI) injection via this novel mechanism. This chapter provides clinical pearls on how to appropriately prescribe and administer Abilify Maintena®.